February 25, 2011
MINNEAPOLISCargill announced it received a no objection letter from FDA regarding GRAS status for arachidonic acid-rich oil (ARA), a nutritional ingredient for infant formula.
We are very pleased about this development relating to this key ingredient for our U.S. infant formula customers," said David Henstrom, vice president, Cargill Health & Nutrition. Our patent and regulatory efforts, along with the start-up of our new facility in Gedian, China, last year, provides a new, reliable option for our customers."
ARA, a component of mothers milk, is an omega-6 fatty acid that is essential for infant brain and vision development.
You May Also Like
CRN petition to FTC: RCTs aren’t required to substantiate ‘health-benefit’ claimsSep 22, 2023
Collagen peptide ingredient solutions for seniors’ changing needs – infographicSep 19, 2023
Radicle Insights—Covid Eris and dietary supplements: separating fact from fictionSep 21, 2023
More bioavailable hyaluronic acid complex for today’s beauty-from-within consumer – snapshotSep 18, 2023